Cargando…

Second and subsequent tumours among 1927 retinoblastoma patients diagnosed in Britain 1951–2004

BACKGROUND: Retinoblastoma is an eye tumour of childhood that occurs in heritable and non-heritable forms. In the heritable form, there is a predisposition to the development of non-ocular subsequent primary tumours (SPTs). METHODS: This study included 1927 retinoblastoma patients diagnosed in Brita...

Descripción completa

Detalles Bibliográficos
Autores principales: MacCarthy, A, Bayne, A M, Brownbill, P A, Bunch, K J, Diggens, N L, Draper, G J, Hawkins, M M, Jenkinson, H C, Kingston, J E, Stiller, C A, Vincent, T J, Murphy, M F G
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3694232/
https://www.ncbi.nlm.nih.gov/pubmed/23674091
http://dx.doi.org/10.1038/bjc.2013.228
_version_ 1782274834008375296
author MacCarthy, A
Bayne, A M
Brownbill, P A
Bunch, K J
Diggens, N L
Draper, G J
Hawkins, M M
Jenkinson, H C
Kingston, J E
Stiller, C A
Vincent, T J
Murphy, M F G
author_facet MacCarthy, A
Bayne, A M
Brownbill, P A
Bunch, K J
Diggens, N L
Draper, G J
Hawkins, M M
Jenkinson, H C
Kingston, J E
Stiller, C A
Vincent, T J
Murphy, M F G
author_sort MacCarthy, A
collection PubMed
description BACKGROUND: Retinoblastoma is an eye tumour of childhood that occurs in heritable and non-heritable forms. In the heritable form, there is a predisposition to the development of non-ocular subsequent primary tumours (SPTs). METHODS: This study included 1927 retinoblastoma patients diagnosed in Britain from 1951 to 2004. Ascertainment was through the (UK) National Registry of Childhood Tumours; cases were followed-up for the occurrence of SPTs. Standardised incidence ratios (SIRs) were calculated. RESULTS: We identified 169 SPTs in 152 patients. The SIR analysis included 145 SPTs with cancer registrations from the years 1971 to 2009. These tumours occurred in 132 patients: 112 of the 781 heritable and 20 of the 1075 (presumed) non-heritable cases under surveillance at the start of this period developed at least one registered SPT. The SIRs for all tumours combined were 13.7 (95% confidence interval 11.3–16.5) in heritable cases and 1.5 (0.9–2.3) in non-heritable cases. The main types of SPT in the heritable cases were leiomyosarcoma, (31 cases; SIR 1018.7 (692.2–1446.0)), osteosarcoma (26 cases; SIR 444.6 (290.4–651.4)), and skin melanoma (12 cases; SIR 18.6 (9.6–32.4)). CONCLUSION: The risk of SPTs in heritable retinoblastoma is extremely high. This has important implications for the clinical follow-up and counselling of survivors and their families.
format Online
Article
Text
id pubmed-3694232
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-36942322014-06-25 Second and subsequent tumours among 1927 retinoblastoma patients diagnosed in Britain 1951–2004 MacCarthy, A Bayne, A M Brownbill, P A Bunch, K J Diggens, N L Draper, G J Hawkins, M M Jenkinson, H C Kingston, J E Stiller, C A Vincent, T J Murphy, M F G Br J Cancer Clinical Study BACKGROUND: Retinoblastoma is an eye tumour of childhood that occurs in heritable and non-heritable forms. In the heritable form, there is a predisposition to the development of non-ocular subsequent primary tumours (SPTs). METHODS: This study included 1927 retinoblastoma patients diagnosed in Britain from 1951 to 2004. Ascertainment was through the (UK) National Registry of Childhood Tumours; cases were followed-up for the occurrence of SPTs. Standardised incidence ratios (SIRs) were calculated. RESULTS: We identified 169 SPTs in 152 patients. The SIR analysis included 145 SPTs with cancer registrations from the years 1971 to 2009. These tumours occurred in 132 patients: 112 of the 781 heritable and 20 of the 1075 (presumed) non-heritable cases under surveillance at the start of this period developed at least one registered SPT. The SIRs for all tumours combined were 13.7 (95% confidence interval 11.3–16.5) in heritable cases and 1.5 (0.9–2.3) in non-heritable cases. The main types of SPT in the heritable cases were leiomyosarcoma, (31 cases; SIR 1018.7 (692.2–1446.0)), osteosarcoma (26 cases; SIR 444.6 (290.4–651.4)), and skin melanoma (12 cases; SIR 18.6 (9.6–32.4)). CONCLUSION: The risk of SPTs in heritable retinoblastoma is extremely high. This has important implications for the clinical follow-up and counselling of survivors and their families. Nature Publishing Group 2013-06-25 2013-05-14 /pmc/articles/PMC3694232/ /pubmed/23674091 http://dx.doi.org/10.1038/bjc.2013.228 Text en Copyright © 2013 Cancer Research UK http://creativecommons.org/licenses/by-nc-sa/3.0/ From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
spellingShingle Clinical Study
MacCarthy, A
Bayne, A M
Brownbill, P A
Bunch, K J
Diggens, N L
Draper, G J
Hawkins, M M
Jenkinson, H C
Kingston, J E
Stiller, C A
Vincent, T J
Murphy, M F G
Second and subsequent tumours among 1927 retinoblastoma patients diagnosed in Britain 1951–2004
title Second and subsequent tumours among 1927 retinoblastoma patients diagnosed in Britain 1951–2004
title_full Second and subsequent tumours among 1927 retinoblastoma patients diagnosed in Britain 1951–2004
title_fullStr Second and subsequent tumours among 1927 retinoblastoma patients diagnosed in Britain 1951–2004
title_full_unstemmed Second and subsequent tumours among 1927 retinoblastoma patients diagnosed in Britain 1951–2004
title_short Second and subsequent tumours among 1927 retinoblastoma patients diagnosed in Britain 1951–2004
title_sort second and subsequent tumours among 1927 retinoblastoma patients diagnosed in britain 1951–2004
topic Clinical Study
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3694232/
https://www.ncbi.nlm.nih.gov/pubmed/23674091
http://dx.doi.org/10.1038/bjc.2013.228
work_keys_str_mv AT maccarthya secondandsubsequenttumoursamong1927retinoblastomapatientsdiagnosedinbritain19512004
AT bayneam secondandsubsequenttumoursamong1927retinoblastomapatientsdiagnosedinbritain19512004
AT brownbillpa secondandsubsequenttumoursamong1927retinoblastomapatientsdiagnosedinbritain19512004
AT bunchkj secondandsubsequenttumoursamong1927retinoblastomapatientsdiagnosedinbritain19512004
AT diggensnl secondandsubsequenttumoursamong1927retinoblastomapatientsdiagnosedinbritain19512004
AT drapergj secondandsubsequenttumoursamong1927retinoblastomapatientsdiagnosedinbritain19512004
AT hawkinsmm secondandsubsequenttumoursamong1927retinoblastomapatientsdiagnosedinbritain19512004
AT jenkinsonhc secondandsubsequenttumoursamong1927retinoblastomapatientsdiagnosedinbritain19512004
AT kingstonje secondandsubsequenttumoursamong1927retinoblastomapatientsdiagnosedinbritain19512004
AT stillerca secondandsubsequenttumoursamong1927retinoblastomapatientsdiagnosedinbritain19512004
AT vincenttj secondandsubsequenttumoursamong1927retinoblastomapatientsdiagnosedinbritain19512004
AT murphymfg secondandsubsequenttumoursamong1927retinoblastomapatientsdiagnosedinbritain19512004